(Q48586505)

13 February 2018

title

Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. (English)

1 reference

13 February 2018

1 reference

6

Rejko Krüger

1 reference

13 February 2018

Ludger Schöls

2

object named as

Ludger Schöls

1 reference

13 February 2018

author name string

Thorsten Schulte

1

1 reference

13 February 2018

Thomas Müller

3

1 reference

13 February 2018

Dirk Woitalla

4

1 reference

13 February 2018

Klaus Berger

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 June 2002

1 reference

13 February 2018

published in

Neuroscience Letters

1 reference

13 February 2018

volume

326

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

70-72

1 reference

13 February 2018

A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900301-4

7 January 2021

10.1016/S0304-3940(02)00301-4

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018